Football (n = 22) | Usual care (n = 19) | Total (n = 41) | |
---|---|---|---|
Age (years) | 68.9 (8.4) | 67.3 (7.0) | 68.2 (7.7) |
Employment status | |||
Paid work | 6 (27%) | 4 (21%) | 10 (24%) |
Retired | 16 (73%) | 15 (79%) | 31 (76%) |
Education | |||
No education | 3 (14%) | 0 (0%) | 3 (7%) |
Lower secondary education (9th/10th grade) | 1 (5%) | 1 (5%) | 2 (5%) |
Vocational education | 6 (27%) | 7 (37%) | 13 (32%) |
Upper secondary education (12th grade) | 2 (9%) | 2 (11%) | 4 (10%) |
College or higher | 10 (45%) | 9 (47%) | 19 (46%) |
Marital status | |||
Married or living with partner | 17 (77%) | 17 (89%) | 34 (83%) |
Others (single, divorced, widowed) | 5 (23%) | 2 (11%) | 7 (17%) |
Time since diagnosis, days | 1099 (941) | 1152 (953) | 1123 (935) |
ISUP Gleason grading (score) | |||
Group 2 (3 + 4) | 3 (14%) | 2 (11%) | 5 (12%) |
Group 3 (4 + 3) | 2 (9%) | 4 (21%) | 6 (15%) |
Group 4 (8) | 4 (18%) | 3 (16%) | 7 (17%) |
Group 5 (9–10) | 13 (59%) | 8 (42%) | 21 (51%) |
Not known | 0 (0%) | 2 (11%) | 2 (5%) |
Treatment at baseline | |||
Current | |||
Anti-androgen monotherapy | 1 (5%) | 1 (5%) | 2 (5%) |
Castration (surgical or pharmacological) | 21 (95%) | 18 (95%) | 39 (95%) |
Previous or current chemotherapy (docetaxel) | 9 (47%) | 7 (32%) | 16 (39%) |
Number of co-morbidities | |||
Zero | 6 (27%) | 9 (47%) | 15 (37%) |
One | 4 (18%) | 3 (16%) | 7 (17%) |
Two | 6 (27%) | 3 (16%) | 9 (22%) |
Three or more | 6 (27%) | 4 (21%) | 10 (24%) |
Bone lesion site | |||
Pelvis | 16 (73%) | 9 (47%) | 25 (61%) |
Femur | 2 (9%) | 5 (26%) | 7 (17%) |
Rib/thoracic spine | 11 (50%) | 10 (53%) | 21 (51%) |
Lumbar spine | 8 (36%) | 3 (16%) | 11 (27%) |
Humerus | 0 (0%) | 1 (5%) | 1 (2%) |
All regions | 2 (9%) | 3 (16%) | 5 (12%) |
Other sites | 0 (0%) | 1 (5%) | 1 (2%) |
Unknown | 0 (0%) | 3 (16%) | 3 (7%) |